Preferences help
enabled [disable] Abstract
Number of results
2012 | 7 | 1 | 25-29
Article title

Alteration of secretory IgA in human breast milk and stool samples after the intake of a probiotic - report of 2 cases

Title variants
Languages of publication
Only a few studies reveal immunological changes in breast milk after the intake of probiotic and none focus on secretory IgA (sIgA). The aim our report was to investigate the levels of sIgA in human breast milk and stools before and after 4 weeks of probiotic intake in a patient with ulcerative colitis (UC) and a control. The study included 2 lactating women: 1 with UC and 1 control. Both received daily 3.75 billion viable Lactobacillus bulgaricus for 28 days. SIgA was measured in breast milk and stools before and after the probiotic intake. The concentration of sIgA in breast milk before the probiotic intake in UC was 408.5 vs 137.4 µg/ml in contol. Fecal sIgA in UC was 420 vs 274 µg/ml in control. After 28 days of probiotic intake there was a decrease in breast milk sIgA in UC but an increase in control - 266.7 vs 914 µg/ml respectively. There was an increase in fecal sIgA both in UC and control - 674.4 vs 1033 µg/ml. It is tempting to speculate that the different sIgA secretion towards the probiotic may be a result of an altered mucosal immune response in UC.
Physical description
1 - 2 - 2012
24 - 11 - 2011
  • Clinic of Gastroenterology, St. Ivan Rilsky University Hospital, 15 Acad. Ivan Geshov blvd, Sofia, 1431, Bulgaria
  • Clinic of Clinical Immunology, University Hospital Alexandrovska, Sofia, 1431, POBox 45, Bulgaria
  • [1] Strober W., Kelsall B., Marth T., Oral tolerance, J. Clin. Immunol., 1998, 18, 1–30[Crossref]
  • [2] Vaz N., Faria A.M.C., Verdolin B.A., Carvalho C.R., Immaturity, Ageing and Oral Tolerance, Scand. J. Immunology, 1997, 46, 225–229[Crossref]
  • [3] Weiner H.L., Oral tolerance, an active immunologic process mediated by multiple mechanisms, J. Clin. Invest., 2000, 106, 1031–1038[Crossref]
  • [4] Goldblum R., Hanson L., Brandtzaeg P., The mucosal defense system, In: Stiehm E., (Ed.), Immunological Disorders in Infants and Children, 3rd ed., Saunders, Philadelphia, 1996
  • [5] Brandtzaeg P. The secretory immunoglobulin system: regulation and biological significance, In: Isaacs C., Davis M., Hanson L., Wright A. (Eds.), Research Agenda for the Millenium: Integrating Population Outcomes, Biological Mechanisms and Research Methods in the Study of Human Milk and Lactation, Kluwer Academic/Plenum Publ., San Diego, 2002
  • [6] Brandtzaeg P., Pabst R., Let’s go mucosal: communication on slippery ground, Trends Immunology, 2004, 25, 570–577[Crossref]
  • [7] Fagarasan S., Honjo T., Intestinal IgA Synthesis: Regulation of Front-line Body Defenses, Nat. Rev. Immunology., 2003, 3, 63–72[Crossref]
  • [8] Picker L.J., Butcher E.C., Physiological and Molecular Mechanisms of Lymphocyte Homing, Annu. Rev. Immunol, 1992, 10, 561–591[Crossref]
  • [9] Kaetzel C.S., Robinson J.K., Chintalacharuvu K.R., Vaerman J.P., Lamm M.E., The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA, Proc Natl. Acad. Sci., 1991, 88, 8796–8800[Crossref]
  • [10] Hanson L.A., Dahlman-Hoglund A., Karlsson M., Lundin S., Dahlgren U., Telemo E., Normal microbial flora of the gut and the immune system, In: Hanson L.A., Yolken R.H. (Eds.), Probiotics, Other Nutritional Factors, and Intestinal Microflora, Lippincott-Raven Publishers, Philadelphia, 1999
  • [11] Hanson L.A., Korotkova M., The role of breastfeeding in prevention of neonatal infection, Semin. Neonatol., 2002, 7, 275–281 [Crossref]
  • [12] Ghosh S., van Heel D., Playford R.J., Probiotics in IBD: is it all gut flora modulation?, Gut, 2004, 53, 620–622[Crossref]
  • [13] Bogunovic M., Dave S.H., Tilstra J.S., Chang D.T., Harpaz N., Xiong H. et al., Enteroendocrine cells express functional toll-like receptors, Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 3, 76–84 [WoS]
  • [14] Isolauri E., Sutas Y., Kankaanpaa P., Avilommi H., Salminen S., Probiotics: effects on immunity, Am. J. Clin. Nutr., 2001, 73, 444S–450S
  • [15] Aldinucci C., Bellussi L., Monciatti G., Passàli G.C., Salerni L., Passàli D. et al, Effects of dietary youghurt on immunological and clinical parameters of rhinopathic patients, Eur. J. Clin. Nutr., 2002, 56, 1155–1161[Crossref]
  • [16] Arunachalam K., Gill H.S., Chandra R.K., Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019), Eur. J. Clin. Nutr., 2000, 54, 263–267[Crossref]
  • [17] Isolauri E., Arvola T., Sutas Y., Moilanen E., Salminen S., Probiotics in the management of atopic eczema, Clin. Exp. Allergy, 2000, 30, 1604–1610[Crossref]
  • [18] Kalliomaki M., Salminen S., Poussa T., Arvilommi H., Isolauri E., Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo controlled trial, Lancet, 2003, 361, 1869–1871[Crossref]
  • [19] Schultz M., Göttl C., Young R.J., Iwen P., Vanderhoof J.A., Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization, J. Pediatr. Gastroenterol. Nutr., 2004, 38, 244–246[Crossref]
  • [20] Rautava S., Kalliomäki M., Isolauri E., Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic disease in the infant, J. Allergy Clin. Immunol., 2002, 109, 119–121[Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.